User: Guest  Login
Document type:
Meeting Abstract
Author(s):
Ettl, J.; Quek, R. G. W.; Bhattacharyya, H.; Rugo, H. S.; Hurvitz, S. A.; Goncalves, A.
Title:
Patient Reported Outcomes (PRO) in patients (pts) with HER2-advanced breast cancer (ABC) and a germline BRCA1/2 mutation (gBRCAm) receiving talazoparib (TALA) vs physician's choice chemotherapy (PCT) in the EMBRACA trial: A focus on subgroups with/without visceral disease
Journal title abbreviation:
Ann Oncol
Year:
2019
Journal volume:
30 Suppl 5
Pages contribution:
129-+
Print-ISSN:
0923-7534
TUM Institution:
Frauenklinik und Poliklinik
 BibTeX